Development and validation of a highly sensitive gas chromatographic–mass spectrometric screening method for the simultaneous determination of nanogram levels of fentanyl, sufentanil and alfentanil in air and surface contamination wipes
- 25 March 2004
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1035 (2) , 249-259
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Development and validation of an HPLC assay for fentanyl, alfentanil, and sufentanil in swab samplesJournal of Pharmaceutical and Biomedical Analysis, 2000
- Clinical Pharmacokinetics of Transdermal OpioidsClinical Pharmacokinetics, 2000
- Proposal for the assessment of quantitative dermal exposure limits in occupational environments: Part 1. Development of a concept to derive a quantitative dermal occupational exposure limit.Occupational and Environmental Medicine, 1998
- Development of a Gas Chromatographic--Mass Spectrometric Drug Screening Method for the N-Dealkylated Metabolites of Fentanyl, Sufentanil, and AlfentanilJournal of Chromatographic Science, 1997
- Clinical Pharmacokinetics of Alfentanil, Fentanyl and SufentanilClinical Pharmacokinetics, 1996
- Occupational Hygiene Measurement Strategy in the Pharmaceutical IndustryOccupational Medicine, 1989
- Establishing Airborne Exposure Control Limits in the Pharmaceutical IndustryAIHA Journal, 1988
- Clinical Pharmacokinetics of Fentanyl and its Newer DerivativesClinical Pharmacokinetics, 1983